![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1h-pyrazol-4-yl)-1h-(1,2,3)triazolo(4,5-b)pyrazine
2. Azd6094
3. Hmpl-504
4. Volitinib
1. Volitinib
2. 1313725-88-0
3. Azd-6094
4. Hmpl-504
5. Azd6094
6. Savolitinib [inn]
7. Hmpl504
8. (s)-1-(1-(imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1h-pyrazol-4-yl)-1h-[1,2,3]triazolo[4,5-b]pyrazine
9. Chembl3334567
10. 2a2da6857r
11. 1h-1,2,3-triazolo(4,5-b)pyrazine, 1-((1s)-1-imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1h-pyrazol-4-yl)-
12. 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
13. Orpathys
14. Unii-2a2da6857r
15. Azd6094, Hmpl-504
16. Volitinib(savolitinib)
17. Azd-6094volitinib
18. Savolitinib (usan/inn)
19. Savolitinib [usan:inn]
20. Savolitinib [usan]
21. Savolitinib [who-dd]
22. Gtpl9918
23. Hmpl 504
24. Schembl12489208
25. Ex-a845
26. Dtxsid801111016
27. Azd 6094
28. Bdbm50023342
29. Mfcd28359096
30. Nsc782121
31. Nsc800966
32. S7674
33. Akos030526403
34. Savolitinib(azd6094, Hmpl-504)
35. Zinc149738712
36. Ccg-267976
37. Db12048
38. Nsc-782121
39. Nsc-800966
40. Compound 28 [pmid: 25148209]
41. Ncgc00475727-01
42. Ac-35267
43. As-35250
44. Bv160378
45. Hy-15959
46. Savolitinib;volitinib;hmpl-504;azd-6094
47. A14419
48. D11139
49. J-690125
50. Q27254463
51. (3e)-5-chloro-3-[(5-{3-[(4-methyl-1,4-diazepan-1-yl)carbonyl]phenyl}-2-furyl)methylene]-1,3-dihydro-2h-indol-2-one Hydrochloride
52. 1-((s)-1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1h-pyrazol-4-yl)-1h-(1,2,3)-triazolo(4,5-b)pyrazine
53. 4-{1-[(1s)-1-{imidazo[1,2-a]pyridin-6-yl}ethyl]-1h-[1,2,3]triazolo[4,5-b]pyrazin-6-yl}-1-methyl-1h-pyrazole
Molecular Weight | 345.4 g/mol |
---|---|
Molecular Formula | C17H15N9 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 345.14504152 g/mol |
Monoisotopic Mass | 345.14504152 g/mol |
Topological Polar Surface Area | 91.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 505 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of lung cancer
Treatment of renal neoplasms